JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (2005) 34 247-256    DOI: 10.1677/jme.1.01687
© 2005 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walthers, E. A
Right arrow Articles by Moore, F. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walthers, E. A
Right arrow Articles by Moore, F. L

Cloning, pharmacological characterization and tissue distribution of an ORL1 opioid receptor from an amphibian, the rough-skinned newt Taricha granulosa

Eliza A Walthers, C Samuel Bradford and Frank L Moore

Department of Zoology, Oregon State University, Corvallis, OR 97331, USA

(Requests for offprints should be addressed to F L Moore; Email: mooref{at}science.oregonstate.edu)

We have cloned and characterized an opioid receptor-like (ORL1; also referred to as NOP) receptor from a urodele amphibian, the rough-skinned newt Taricha granulosa The cDNA clone encodes a protein of 368 amino acids that contains the seven hydrophobic domains characteristic of G-protein-coupled receptors, and has the highest sequence identity to the frog (Rana pipiens) nociceptin-like and human ORL1 opioid receptors (79.6 and 68.4%, respectively). Saturation binding assays on membranes from COS-7 cells transiently expressing the newt ORL1 (nORL) receptor revealed a single, high-affinity (estimated Kd, 0.1974 nM) binding site for the ORL1-specific agonist [3H]orphanin FQ analog ([3H]oFQ). In competition binding assays, the [3H]oFQ-binding site, like the mammalian ORL1 receptor, had no affinity for the non-selective opioid receptor antagonist naloxone, the {kappa}-selective agonists U69593 and U50488, or the µ- and {delta}-selective opioid receptor agonists DAMGO and DPDPE, respectively. However, the nORL receptor displayed higher affinities for the {kappa}-selective agonists dynorphin A (1–13), dynorphin B, and dynorphin A (1–8) (Ki values, 2.8, 151.8, and 183.0 nM, respectively) than its mammalian homologue. The tissue distribution of the nORL receptor, as determined by reverse transcriptase PCR, was also found to differ from reports on the mammalian ORL1 receptor, with mRNA detected in brain, spinal cord, and lung, but not detected in a number of other peripheral tissues reported to express the receptor in mammals. This is the first report describing the expression and characterization of an amphibian ORL1 receptor, and contributes to our understanding of the evolution of the opioid system.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Dreborg, G. Sundstrom, T. A. Larsson, and D. Larhammar
Evolution of vertebrate opioid receptors
PNAS, October 7, 2008; 105(40): 15487 - 15492.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
C S. Bradford, E. A Walthers, B. T Searcy, and F. L Moore
Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa
J. Mol. Endocrinol., June 1, 2005; 34(3): 809 - 823.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.